CoChat

Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case–control study nested in the Danish National Birth Cohort

Open access
Bonefeld-Jørgensen, Eva C., Long, Manhai, Fredslund, Stine Overvad, Bossi, Rossana, Olsen, Jørn · 2014 · Cancer Causes & Control
Cited by 140

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Animal studies have indicated that perfluoroalkylated substances (PFAS) increase mammary fibroadenomas. A recent case-control study in Greenlandic Inuit women showed an association between the PFAS serum levels and breast cancer (BC) risk. The present study evaluates the association between serum levels of PFAS in pregnant Danish women and the risk of premenopausal BC during a follow-up period of 10-15 years using prospectively collected exposure data during the pregnancy. METHODS: Questionnaire and blood samples were taken during 1996-2002 and at the end of follow-up, all 250 BC cases and 233 frequency-matched controls were chosen for further analyses. Serum levels of ten perfluorocarboxylated acids, five perfluorosulfonated acids, and one sulfonamide (perflurooctane-sulfonamide, PFOSA) were determined by liquid chromatography-tandem mass spectrometry with electrospray ionization in negative mode. Computer-assisted telephone interviews taken during pregnancy provided data on potential confounders. RESULTS: Weak positive and negative insignificant associations were found between BC risk and levels of perfluorooctane sulfonamide (PFOSA) and perfluorohexanesulfonate (PFHxS), respectively. Grouped into quintile, the BC cases had a significant positive association with PFOSA at the highest quintiles and a negatively association for PFHxS. Sensitivity analyses excluding uncertain cases caused stronger data for PFOSA and weaker for PFHxS. No further significant associations were observed. CONCLUSIONS: This study does not provide convincing evidence for a causal link between PFAS exposures and premenopausal BC risks 10-15 years later.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10552-014-0446-7

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90 · DOI · Paper page
  2. Campeau P, Foulkes W, Tischkowitz M (2008) Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124:31–42 · DOI · Paper page
  3. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345–1389 · DOI · Paper page
  4. Fredslund SO, Bonefeld-Jorgensen EC (2012) Breast cancer in the Arctic—changes over the past decades. Int J Circumpolar Health 71:19155 · DOI
  5. Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T, Ghisari M, Mulvad G, Kern P, Nzulumiki P, Dewailly E (2011) Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health 10:88 · DOI · Paper page
  6. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN (1995) Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 87:1681–1685 · DOI · Paper page
  7. Sargent JW, Seffl RJ (1970) Properties of perfluorinated liquids. Fed Proc 29:1699–1703
  8. Dimitrov S, Kamenska V, Walker JD, Windle W, Purdy R, Lewis M, Mekenyan O (2004) Predicting the biodegradation products of perfluorinated chemicals using CATABOL. SAR QSAR Environ Res 15:69–82 · DOI · Paper page
  9. Giesy JP, Kannan K, Jones PD (2001) Global biomonitoring of perfluorinated organics. Sci World J 1:627–629 · DOI · Paper page
  10. Stockholmconvention (2009–2014) Fourth meeting of the conference of the parties of the Stockholm convention. Stockholm convention on persistent organic pollutants. Geneve, Switzerland
  11. Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, Zobel LR (2004) Characterization of risk for general population exposure to perfluorooctanoate. Regul Toxicol Pharmacol 39:363–380 · DOI
  12. Fuentes S, Vicens P, Colomina MT, Domingo JL (2007) Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology 242:123–129 · DOI
  13. Johansson N, Eriksson P, Viberg H (2009) Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 108:412–418 · DOI · Paper page
  14. Hardisty JF, Willson GA, Brown WR, McConnell EE, Frame SR, Gaylor DW, Kennedy GL, Butenhoff JL (2010) Pathology Working Group review and evaluation of proliferative lesions of mammary gland tissues in female rats fed ammonium perfluorooctanoate (APFO) in the diet for 2 years. Drug Chem Toxicol 33:131–137 · DOI
  15. Butenhoff JL, Kennedy GL Jr, Chang SC, Olsen GW (2012) Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague–Dawley rats. Toxicology 298:1–13 · DOI
  16. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C, Fenton SE (2007) Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96:133–144 · DOI · Paper page
  17. Kropp T, Houlihan J (2005) Evaluating human health risks from exposure to perfluorooctanoic acid (PFOA): recommendations to the Science Advisory Board’s PFOA Review Panel. In: Presented February 10, 2005 to the US EPA Science Advisory Board’s PFOA Review Panel, in Washington, DC
  18. Ghisari M, Eiberg H, Long M, Bonefeld-Jørgensen EC (2014) Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case–control study in Inuit women. Environ Health 13(1):19 · DOI
  19. Olsen J, Melbye M, Olsen SF, Sorensen TI, Aaby P, Andersen AM, Taxbol D, Hansen KD, Juhl M, Schow TB, Sorensen HT, Andresen J, Mortensen EL, Olesen AW, Sondergaard C (2001) The Danish National Birth Cohort—its background, structure and aim. Scand J Public Health 29:300–307 · DOI · Paper page
  20. Keller JM, Calafat AM, Kato K, Ellefson ME, Reagen WK, Strynar M, O’Connell S, Butt CM, Mabury SA, Small J, Muir DC, Leigh SD, Schantz MM (2010) Determination of perfluorinated alkyl acid concentrations in human serum and milk standard reference materials. Anal Bioanal Chem 397:439–451 · DOI
  21. Olsen GW, Church TR, Larson EB, van Belle G, Lundberg JK, Hansen KJ, Burris JM, Mandel JH, Zobel LR (2004) Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle Washington. Chemosphere 54:1599–1611 · DOI · Paper page
  22. Lehmler HJ (2005) Synthesis of environmentally relevant fluorinated surfactants—a review. Chemosphere 58:1471–1496 · DOI · Paper page
  23. Olsen GW, Church TR, Miller JP, Burris JM, Hansen KJ, Lundberg JK, Armitage JB, Herron RM, Medhdizadehkashi Z, Nobiletti JB, O’Neill EM, Mandel JH, Zobel LR (2003) Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111:1892–1901 · DOI · Paper page
  24. Starkov AA, Wallace KB (2002) Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol Sci 66:244–252 · DOI · Paper page
  25. Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC (2006) Biological monitoring of polyfluoroalkyl substances: a review. Environ Sci Technol 40:3463–3473 · DOI · Paper page
  26. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Tully JS, Needham LL (2007) Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 41:2237–2242 · DOI · Paper page
  27. Calafat AM, Needham LL, Kuklenyik Z, Reidy JA, Tully JS, Aguilar-Villalobos M, Naeher LP (2006) Perfluorinated chemicals in selected residents of the American continent. Chemosphere 63:490–496 · DOI · Paper page
  28. Karrman A, van Bavel B, Jarnberg U, Hardell L, Lindstrom G (2006) Perfluorinated chemicals in relation to other persistent organic pollutants in human blood. Chemosphere 64:1582–1591 · DOI · Paper page
  29. Karrman A, Langlois I, van Bavel B, Lindstrom G, Oehme M (2007) Identification and pattern of perfluorooctane sulfonate (PFOS) isomers in human serum and plasma. Environ Int 33:782–788 · DOI
  30. Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, Lignell S, Lindstrom G (2007) Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996–2004, in Sweden. Environ Health Perspect 115:226–230 · DOI · Paper page
  31. Beesoon S, Genuis SJ, Benskin JP, Martin JW (2012) Exceptionally high serum concentrations of perfluorohexanesulfonate in a Canadian family are linked to home carpet treatment applications. Environ Sci Technol 46:12960–12967 · DOI · Paper page
  32. Gump BB, Wu Q, Dumas AK, Kannan K (2011) Perfluorochemical (PFC) exposure in children: associations with impaired response inhibition. Environ Sci Technol 45:8151–8159 · DOI · Paper page
  33. Stein CR, Savitz DA (2011) Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age. Environ Health Perspect 119:1466–1471 · DOI · Paper page
  34. Lim TC, Wang B, Huang J, Deng S, Yu G (2011) Emission inventory for PFOS in China: review of past methodologies and suggestions. Sci World J 11:1963–1980 · DOI · Paper page
  35. Kjeldsen LS, Bonefeld-Jorgensen EC (2013) Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res 20:8031–8044 · DOI · Paper page
  36. Rosenmai AK, Nielsen FK, Pedersen M, Hadrup N, Trier X, Christensen JH, Vinggaard AM (2013) Fluorochemicals used in food packaging inhibit male sex hormone synthesis. Toxicol Appl Pharmacol 266:132–142 · DOI
  37. Eriksen KT, Raaschou-Nielsen O, Sorensen M, Roursgaard M, Loft S, Moller P (2010) Genotoxic potential of the perfluorinated chemicals PFOA, PFOS, PFBS, PFNA and PFHxA in human HepG2 cells. Mutat Res 700:39–43 · DOI · Paper page
  38. Florentin A, Deblonde T, Diguio N, Hautemaniere A, Hartemann P (2011) Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: cytotoxicity but no genotoxicity? Int J Hyg Environ Health 214:493–499 · DOI
  39. Yao X, Zhong L (2005) Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat Res Genet Toxicol Environ Mutagen 587:38–44 · DOI
  40. Huang Q, Zhang J, Martin FL, Peng S, Tian M, Mu X, Shen H (2013) Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. Toxicol Lett 223:211–220 · DOI
  41. Grandjean P, Budtz-Jorgensen E (2013) Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health 12:35 · DOI · Paper page

Cited by

See all 140

Metadata

Authors
Bonefeld-Jørgensen, E. C., Long, M., Fredslund, S. O., Bossi, R., & Olsen, J.
Venue
Cancer Causes & Control
Published
2014-08-23
Volume
25
Issue
11
Pages
1439-1448
ISSN
  • 0957-5243 (ISSN-L)
  • 1573-7225
OpenAlex
W1977968996
Cited by
140
References
12
FWCI
5.59
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.